| amine metabolic process | GO:0009308 | 45 | 0.225 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.181 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.178 | |
| sterol metabolic process | GO:0016125 | 58 | 0.173 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.161 | |
| steroid metabolic process | GO:0008202 | 119 | 0.136 | |
| oxidation reduction process | GO:0055114 | 342 | 0.135 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.127 | |
| transmembrane transport | GO:0055085 | 412 | 0.124 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.117 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.108 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.099 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.090 | |
| spermatogenesis | GO:0007283 | 284 | 0.088 | |
| coagulation | GO:0050817 | 78 | 0.087 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.085 | |
| cell adhesion | GO:0007155 | 329 | 0.083 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.081 | |
| organic anion transport | GO:0015711 | 137 | 0.078 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.078 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.074 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.072 | |
| lipid catabolic process | GO:0016042 | 69 | 0.071 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.071 | |
| mapk cascade | GO:0000165 | 281 | 0.070 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.069 | |
| regulation of acetylcholine secretion neurotransmission | GO:0014056 | 2 | 0.066 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.066 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.066 | |
| wound healing | GO:0042060 | 157 | 0.064 | |
| organic acid transport | GO:0015849 | 101 | 0.062 | |
| axonogenesis | GO:0007409 | 274 | 0.061 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.061 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.060 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.059 | |
| acetylcholine secretion neurotransmission | GO:0014055 | 2 | 0.059 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.059 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.058 | |
| small molecule catabolic process | GO:0044282 | 71 | 0.058 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.057 | |
| regulation of hemostasis | GO:1900046 | 28 | 0.057 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.057 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.056 | |
| organelle fission | GO:0048285 | 170 | 0.056 | |
| positive regulation of dopamine secretion | GO:0033603 | 2 | 0.056 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.055 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.055 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.053 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.052 | |
| norepinephrine transport | GO:0015874 | 2 | 0.052 | |
| regulation of defense response | GO:0031347 | 233 | 0.052 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.051 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.051 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.051 | |
| anion transport | GO:0006820 | 177 | 0.050 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.050 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.049 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.049 | |
| endocytosis | GO:0006897 | 168 | 0.049 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.049 | |
| nuclear division | GO:0000280 | 158 | 0.049 | |
| cellular lipid catabolic process | GO:0044242 | 52 | 0.048 | |
| acetate ester transport | GO:1901374 | 2 | 0.047 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.047 | |
| cytokine production | GO:0001816 | 319 | 0.046 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.045 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.045 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.044 | |
| response to radiation | GO:0009314 | 165 | 0.044 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.044 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.044 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.044 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.043 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.043 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.043 | |
| cellular homeostasis | GO:0019725 | 240 | 0.042 | |
| response to light stimulus | GO:0009416 | 135 | 0.042 | |
| sensory perception | GO:0007600 | 245 | 0.041 | |
| regulation of cell motility | GO:2000145 | 236 | 0.041 | |
| acetylcholine transport | GO:0015870 | 2 | 0.040 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.040 | |
| male gamete generation | GO:0048232 | 285 | 0.040 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.040 | |
| camera type eye development | GO:0043010 | 266 | 0.039 | |
| cholesterol metabolic process | GO:0008203 | 56 | 0.039 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.039 | |
| maintenance of location | GO:0051235 | 89 | 0.039 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.039 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.039 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.039 | |
| regulation of blood coagulation | GO:0030193 | 28 | 0.038 | |
| activation of mapk activity | GO:0000187 | 59 | 0.038 | |
| actin filament organization | GO:0007015 | 113 | 0.038 | |
| hemostasis | GO:0007599 | 78 | 0.038 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.038 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.038 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.038 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.038 | |
| eye photoreceptor cell differentiation | GO:0001754 | 41 | 0.037 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.037 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.037 | |
| skeletal system development | GO:0001501 | 356 | 0.037 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.037 | |
| cation transport | GO:0006812 | 399 | 0.037 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.037 | |
| circulatory system process | GO:0003013 | 197 | 0.036 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.036 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.035 | |
| regulation of ion transport | GO:0043269 | 215 | 0.035 | |
| positive regulation of angiogenesis | GO:0045766 | 46 | 0.035 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.035 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.034 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.034 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.034 | |
| chemotaxis | GO:0006935 | 247 | 0.034 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.034 | |
| photoreceptor cell differentiation | GO:0046530 | 52 | 0.034 | |
| retinoid metabolic process | GO:0001523 | 24 | 0.034 | |
| cholesterol homeostasis | GO:0042632 | 44 | 0.034 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.033 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.032 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.032 | |
| lipid localization | GO:0010876 | 126 | 0.032 | |
| regulation of coagulation | GO:0050818 | 31 | 0.032 | |
| activation of transmembrane receptor protein tyrosine kinase activity | GO:0007171 | 3 | 0.032 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.032 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.031 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.031 | |
| ovulation cycle | GO:0042698 | 59 | 0.031 | |
| neurotransmitter transport | GO:0006836 | 76 | 0.031 | |
| blood coagulation | GO:0007596 | 76 | 0.031 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.031 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.031 | |
| monocarboxylic acid biosynthetic process | GO:0072330 | 61 | 0.031 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.031 | |
| lateral geniculate nucleus development | GO:0021771 | 1 | 0.030 | |
| muscle contraction | GO:0006936 | 101 | 0.030 | |
| synaptic transmission | GO:0007268 | 329 | 0.030 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.030 | |
| dna metabolic process | GO:0006259 | 303 | 0.030 | |
| plasma lipoprotein particle remodeling | GO:0034369 | 6 | 0.030 | |
| neutral lipid metabolic process | GO:0006638 | 57 | 0.030 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.029 | |
| fibrinolysis | GO:0042730 | 3 | 0.029 | |
| regulation of excitatory postsynaptic membrane potential | GO:0060079 | 41 | 0.029 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.029 | |
| norepinephrine secretion | GO:0048243 | 2 | 0.029 | |
| negative regulation of action potential | GO:0045759 | 1 | 0.028 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.028 | |
| establishment of blood nerve barrier | GO:0008065 | 3 | 0.028 | |
| generation of ovulation cycle rhythm | GO:0060112 | 1 | 0.028 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.028 | |
| organic acid catabolic process | GO:0016054 | 51 | 0.028 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.028 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.028 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.028 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.028 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.028 | |
| response to peptide | GO:1901652 | 136 | 0.027 | |
| protein maturation | GO:0051604 | 176 | 0.027 | |
| triglyceride metabolic process | GO:0006641 | 51 | 0.027 | |
| regulation of protein processing | GO:0070613 | 96 | 0.027 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.027 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.027 | |
| regulation of postsynaptic membrane potential | GO:0060078 | 48 | 0.027 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.027 | |
| protein ubiquitination | GO:0016567 | 171 | 0.027 | |
| digestive system development | GO:0055123 | 200 | 0.027 | |
| lipid homeostasis | GO:0055088 | 63 | 0.027 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.027 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.027 | |
| regulation of interleukin 1 beta production | GO:0032651 | 25 | 0.026 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.026 | |
| cell division | GO:0051301 | 120 | 0.026 | |
| skin development | GO:0043588 | 220 | 0.026 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.026 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.026 | |
| motor neuron migration | GO:0097475 | 4 | 0.026 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.026 | |
| positive regulation of catecholamine secretion | GO:0033605 | 2 | 0.025 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.025 | |
| innate immune response | GO:0045087 | 157 | 0.025 | |
| lipoprotein metabolic process | GO:0042157 | 43 | 0.025 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.025 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.025 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.025 | |
| regulation of protein localization | GO:0032880 | 231 | 0.025 | |
| protein oligomerization | GO:0051259 | 67 | 0.025 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.025 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.025 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.025 | |
| acylglycerol metabolic process | GO:0006639 | 55 | 0.025 | |
| drug transmembrane transport | GO:0006855 | 5 | 0.025 | |
| regulation of cell migration | GO:0030334 | 219 | 0.025 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.025 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.025 | |
| smooth muscle contraction | GO:0006939 | 44 | 0.025 | |
| sensory perception of mechanical stimulus | GO:0050954 | 107 | 0.024 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.024 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.024 | |
| cation homeostasis | GO:0055080 | 212 | 0.024 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.024 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.024 | |
| lipid transport | GO:0006869 | 98 | 0.024 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.024 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.024 | |
| placenta development | GO:0001890 | 140 | 0.024 | |
| positive regulation of map kinase activity | GO:0043406 | 84 | 0.024 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.024 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.024 | |
| connective tissue development | GO:0061448 | 179 | 0.024 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.024 | |
| inflammatory response | GO:0006954 | 244 | 0.024 | |
| muscle system process | GO:0003012 | 141 | 0.023 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.023 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.023 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.023 | |
| negative regulation of hemostasis | GO:1900047 | 11 | 0.023 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.023 | |
| regulation of circadian sleep wake cycle sleep | GO:0045187 | 3 | 0.023 | |
| diterpenoid metabolic process | GO:0016101 | 24 | 0.023 | |
| leukocyte migration | GO:0050900 | 124 | 0.023 | |
| ossification | GO:0001503 | 216 | 0.023 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.023 | |
| cell growth | GO:0016049 | 130 | 0.023 | |
| tissue homeostasis | GO:0001894 | 115 | 0.023 | |
| endothelium development | GO:0003158 | 45 | 0.023 | |
| actomyosin structure organization | GO:0031032 | 56 | 0.023 | |
| sterol homeostasis | GO:0055092 | 45 | 0.023 | |
| gland development | GO:0048732 | 330 | 0.022 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.022 | |
| sperm motility | GO:0030317 | 47 | 0.022 | |
| regulation of circadian sleep wake cycle | GO:0042749 | 3 | 0.022 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.022 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.022 | |
| extracellular structure organization | GO:0043062 | 148 | 0.022 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.022 | |
| membrane depolarization | GO:0051899 | 64 | 0.022 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.022 | |
| cholesterol transport | GO:0030301 | 38 | 0.022 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.022 | |
| visual perception | GO:0007601 | 52 | 0.022 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.022 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.022 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.022 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.022 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.022 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.022 | |
| photoreceptor cell development | GO:0042461 | 40 | 0.021 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.021 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.021 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.021 | |
| negative regulation of cholesterol transport | GO:0032375 | 4 | 0.021 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.021 | |
| vesicle localization | GO:0051648 | 86 | 0.021 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.021 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.021 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.021 | |
| response to growth factor | GO:0070848 | 198 | 0.021 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.021 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.021 | |
| nephron tubule development | GO:0072080 | 84 | 0.020 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.020 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.020 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.020 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.020 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.020 | |
| regulation of interleukin 6 production | GO:0032675 | 55 | 0.020 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.020 | |
| response to nutrient levels | GO:0031667 | 109 | 0.020 | |
| protein catabolic process | GO:0030163 | 221 | 0.020 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.020 | |
| lipid storage | GO:0019915 | 36 | 0.020 | |
| sterol transport | GO:0015918 | 38 | 0.020 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.020 | |
| negative regulation of sterol transport | GO:0032372 | 4 | 0.020 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.020 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.020 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.020 | |
| cell fate commitment | GO:0045165 | 210 | 0.020 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.020 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.020 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.019 | |
| cell junction assembly | GO:0034329 | 52 | 0.019 | |
| muscle tissue development | GO:0060537 | 308 | 0.019 | |
| membrane organization | GO:0061024 | 245 | 0.019 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.019 | |
| tumor necrosis factor production | GO:0032640 | 50 | 0.019 | |
| regulation of endocytosis | GO:0030100 | 69 | 0.019 | |
| regulation of interleukin 1 production | GO:0032652 | 26 | 0.019 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.019 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.019 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.019 | |
| defense response to other organism | GO:0098542 | 197 | 0.019 | |
| amide transport | GO:0042886 | 138 | 0.019 | |
| regulation of neurotransmitter levels | GO:0001505 | 87 | 0.019 | |
| positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure | GO:0001988 | 1 | 0.019 | |
| terpenoid metabolic process | GO:0006721 | 25 | 0.019 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.019 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.019 | |
| steroid biosynthetic process | GO:0006694 | 47 | 0.019 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.019 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.019 | |
| intracellular protein transport | GO:0006886 | 204 | 0.019 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.019 | |
| glucose homeostasis | GO:0042593 | 128 | 0.018 | |
| regulation of norepinephrine secretion | GO:0014061 | 2 | 0.018 | |
| negative regulation of inflammatory response | GO:0050728 | 61 | 0.018 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.018 | |
| protein processing | GO:0016485 | 163 | 0.018 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.018 | |
| cellular alcohol metabolic process | GO:0044107 | 3 | 0.018 | |
| organ growth | GO:0035265 | 117 | 0.018 | |
| cholesterol efflux | GO:0033344 | 24 | 0.018 | |
| cellular response to lipid | GO:0071396 | 145 | 0.018 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.018 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.018 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.018 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.018 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.018 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.018 | |
| circadian sleep wake cycle rem sleep | GO:0042747 | 1 | 0.018 | |
| cholesterol esterification | GO:0034435 | 3 | 0.018 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.018 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.018 | |
| rhodopsin mediated signaling pathway | GO:0016056 | 4 | 0.017 | |
| muscle cell development | GO:0055001 | 133 | 0.017 | |
| protein localization to organelle | GO:0033365 | 185 | 0.017 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.017 | |
| regulation of neuron death | GO:1901214 | 134 | 0.017 | |
| multicellular organism growth | GO:0035264 | 161 | 0.017 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.017 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.017 | |
| embryonic placenta development | GO:0001892 | 98 | 0.017 | |
| alpha amino acid metabolic process | GO:1901605 | 59 | 0.017 | |
| glucose metabolic process | GO:0006006 | 92 | 0.017 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.017 | |
| eye photoreceptor cell development | GO:0042462 | 31 | 0.017 | |
| regulation of chemotaxis | GO:0050920 | 53 | 0.017 | |
| positive regulation of skeletal muscle cell differentiation | GO:2001016 | 4 | 0.017 | |
| response to acid chemical | GO:0001101 | 111 | 0.017 | |
| striated muscle cell development | GO:0055002 | 125 | 0.017 | |
| isoprenoid metabolic process | GO:0006720 | 29 | 0.017 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.017 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.017 | |
| renal system development | GO:0072001 | 225 | 0.017 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.017 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.017 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.017 | |
| liver development | GO:0001889 | 66 | 0.017 | |
| regulation of system process | GO:0044057 | 200 | 0.017 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.017 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.017 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.017 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.017 | |
| response to oxidative stress | GO:0006979 | 123 | 0.017 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.017 | |
| forebrain development | GO:0030900 | 302 | 0.017 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.016 | |
| plasma lipoprotein particle clearance | GO:0034381 | 13 | 0.016 | |
| synaptic transmission involved in micturition | GO:0060084 | 3 | 0.016 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.016 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.016 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.016 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.016 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.016 | |
| positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway | GO:0051482 | 4 | 0.016 | |
| angiogenesis | GO:0001525 | 201 | 0.016 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.016 | |
| immune effector process | GO:0002252 | 321 | 0.016 | |
| myosin filament assembly | GO:0031034 | 2 | 0.016 | |
| regulation of lipid biosynthetic process | GO:0046890 | 54 | 0.016 | |
| steroid esterification | GO:0034433 | 3 | 0.016 | |
| hexose metabolic process | GO:0019318 | 98 | 0.016 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.016 | |
| establishment of vesicle localization | GO:0051650 | 81 | 0.016 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.016 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.016 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.016 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.016 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.016 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.016 | |
| regulation of cell growth | GO:0001558 | 91 | 0.016 | |
| regulation of nuclear division | GO:0051783 | 56 | 0.016 | |
| sensory perception of sound | GO:0007605 | 97 | 0.016 | |
| detection of light stimulus | GO:0009583 | 25 | 0.016 | |
| ear development | GO:0043583 | 200 | 0.016 | |
| thermosensory behavior | GO:0040040 | 1 | 0.015 | |
| negative regulation of coagulation | GO:0050819 | 11 | 0.015 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.015 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.015 | |
| organelle localization | GO:0051640 | 179 | 0.015 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.015 | |
| defense response to bacterium | GO:0042742 | 119 | 0.015 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.015 | |
| sodium ion transport | GO:0006814 | 73 | 0.015 | |
| glycerolipid biosynthetic process | GO:0045017 | 50 | 0.015 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.015 | |
| bone morphogenesis | GO:0060349 | 78 | 0.015 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.015 | |
| blood circulation | GO:0008015 | 195 | 0.015 | |
| response to inorganic substance | GO:0010035 | 96 | 0.015 | |
| retina homeostasis | GO:0001895 | 23 | 0.015 | |
| regulation of cholesterol biosynthetic process | GO:0045540 | 8 | 0.015 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.015 | |
| cellular alcohol biosynthetic process | GO:0044108 | 3 | 0.015 | |
| cell maturation | GO:0048469 | 127 | 0.015 | |
| negative regulation of membrane potential | GO:0045837 | 4 | 0.015 | |
| cholesterol catabolic process | GO:0006707 | 5 | 0.015 | |
| myotube differentiation | GO:0014902 | 105 | 0.015 | |
| response to peptide hormone | GO:0043434 | 127 | 0.015 | |
| positive regulation of neuron projection development | GO:0010976 | 79 | 0.015 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.015 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.015 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.015 | |
| regulation of action potential | GO:0098900 | 4 | 0.015 | |
| bone development | GO:0060348 | 120 | 0.015 | |
| detection of abiotic stimulus | GO:0009582 | 60 | 0.015 | |
| lung development | GO:0030324 | 164 | 0.015 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.015 | |
| heart process | GO:0003015 | 94 | 0.014 | |
| response to steroid hormone | GO:0048545 | 56 | 0.014 | |
| cell cell junction organization | GO:0045216 | 72 | 0.014 | |
| protein localization to membrane | GO:0072657 | 108 | 0.014 | |
| regulation of circadian sleep wake cycle rem sleep | GO:0042320 | 1 | 0.014 | |
| response to drug | GO:0042493 | 75 | 0.014 | |
| developmental maturation | GO:0021700 | 193 | 0.014 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.014 | |
| nuclear transport | GO:0051169 | 139 | 0.014 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.014 | |
| mesodermal cell migration | GO:0008078 | 4 | 0.014 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.014 | |
| negative regulation of endothelial cell migration | GO:0010596 | 4 | 0.014 | |
| fat cell differentiation | GO:0045444 | 160 | 0.014 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.014 | |
| actin filament bundle assembly | GO:0051017 | 40 | 0.014 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.014 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.014 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.014 | |
| macromolecule methylation | GO:0043414 | 120 | 0.014 | |
| myosin filament organization | GO:0031033 | 3 | 0.014 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.014 | |
| organelle assembly | GO:0070925 | 177 | 0.014 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.014 | |
| respiratory tube development | GO:0030323 | 167 | 0.014 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.014 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.014 | |
| peptidyl serine phosphorylation | GO:0018105 | 74 | 0.014 | |
| positive regulation of growth | GO:0045927 | 104 | 0.014 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.014 | |
| interleukin 6 production | GO:0032635 | 58 | 0.014 | |
| cytosolic calcium ion homeostasis | GO:0051480 | 70 | 0.014 | |
| innate immune response in mucosa | GO:0002227 | 3 | 0.014 | |
| hormone metabolic process | GO:0042445 | 86 | 0.014 | |
| hepaticobiliary system development | GO:0061008 | 67 | 0.014 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.013 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.013 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.013 | |
| corpus callosum morphogenesis | GO:0021540 | 3 | 0.013 | |
| anion homeostasis | GO:0055081 | 16 | 0.013 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.013 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.013 | |
| cellular amino acid catabolic process | GO:0009063 | 25 | 0.013 | |
| negative regulation of endopeptidase activity | GO:0010951 | 44 | 0.013 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.013 | |
| negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090101 | 61 | 0.013 | |
| molting cycle | GO:0042303 | 90 | 0.013 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.013 | |
| neural tube closure | GO:0001843 | 90 | 0.013 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.013 | |
| negative regulation of blood coagulation | GO:0030195 | 11 | 0.013 | |
| sodium ion transmembrane transport | GO:0035725 | 49 | 0.013 | |
| response to insulin | GO:0032868 | 100 | 0.013 | |
| methylation | GO:0032259 | 134 | 0.013 | |
| intracellular mrna localization | GO:0008298 | 4 | 0.013 | |
| tube formation | GO:0035148 | 140 | 0.013 | |
| respiratory system development | GO:0060541 | 190 | 0.013 | |
| atp metabolic process | GO:0046034 | 75 | 0.013 | |
| lipoprotein biosynthetic process | GO:0042158 | 33 | 0.013 | |
| striated muscle myosin thick filament assembly | GO:0071688 | 1 | 0.013 | |
| regulation of heart contraction | GO:0008016 | 77 | 0.013 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.013 | |
